Tag: Omnipod
Insulet’s Omnipod fuels growth
February 23, 2024HME News Staff
ACTON, Mass. – Insulet reported full year 2023 revenues $1.7 billion, up 30% compared to 2022. Fourth quarter 2023 revenue was $509.8 million, up nearly 38%. Total Omnipod revenue was $501 million; of that, US Omnipod revenue was $394.6 million, an increase of nearly 43%. “2023 was another transformational year for Insulet,” said Jim Hollingshead, president & CEO. “The rapid adoption of Omnipod 5 helped fuel our eighth consecutive year of more than 20% constant currency revenue...
Insulet gets FDA clearance for iPhone app
October 24, 2023HME News Staff
ACTON, Mass. – Insulet has received 510(k) clearance from the U.S. Food and Drug Administration for its Omnipod 5 App for iPhone, making Insulet the first company to offer a tubeless automated insulin delivery (AID) system with full control from a compatible Android and iOS smartphone. "Today, we celebrate this significant milestone in our ongoing effort to provide people with diabetes solutions that improve their lives and help them think less about diabetes," said Eric Benjamin, executive...
Insulet’s Omnipod 5 cleared for use ages two and up
August 24, 2022HME News Staff
ACTON, Mass. – Insulet has received U.S. Food and Drug Administration clearance for its Omnipod 5 Automated Insulin Delivery System for individuals aged two years and older with Type 1 diabetes. “We received tremendous first-hand reports of how Omnipod 5 made diabetes management easier for our pivotal trial participants, and the clinical data demonstrated impressive glycemic improvements, as well,” said Dr. Trang Ly, MBBS, FRACP, PhD, Insulet’s senior vice president and medical...
Insulet surpasses $1 billion in Omnipod revenue
February 25, 2022HME News Staff
ACTON, Mass. – Insulet Corporation reported revenue of $307.7 million for the fourth quarter of 2021, and full year revenue of $1.1 billion. Total Omnipod revenue was $275.8 million for the quarter and $1 billion for the full year. Of that, U.S. Omnipod revenue for the year was $651.5 million and international Omnipod revenue of $359.9 million. “2021 was another successful year for Insulet, as we reached an important milestone of over $1 billion in revenue and advanced our strategic priorities,”...
Insulet highlights ‘growing power’ of Omnipod
November 8, 2021HME News Staff
ACTON, Mass. – Insulet Corp. reported revenue of $275.6 million for the third quarter of 2021, up 17.8% over the same period last year.
It reported revenue was $260.3 million, up 22.7%, for Omnipod.
"Our third quarter results reflect the growing power of Omnipod,” said Shacey Petrovic, president and CEO. “We are driving global new customer starts, have momentum across our business, and are advancing exciting new innovations. We continue to share compelling clinical...
Insulet posts Q4 revenue increase, net loss
February 24, 2021HME News Staff
ACTON, Mass. – Insulet reported revenues of $246.1 million for the fourth quarter of 2020, an increase of 17.5% over the same quarter in 2019. Full-year revenues were $904.4 million, an increase of 22.5% compared to the previous year. For the quarter, U.S. Omnipod revenue was $231.1 million and International Omnipod revenue was $149.2 million. Omnipod revenue for the full year was $834.9 million: $526.9 million in U.S. Omnipod...
Insulet extends financial assistance to 'Podders'
April 17, 2020HME News Staff
ACTON, Mass. - Insulet, maker of the OmniPod system, has expanded its U.S. financial assistance program for current customers who have been negatively impacted by COVID-19. Upon meeting certain financial criteria, those customers may receive up to a six-month supply (60 pods). “Our coronavirus response plan is guided by our fundamental principles of protecting the health and safety of our employees, preserving the well-being of the communities in which we live and work, and ensuring that customers...
Insulet reports year-over-year growth
February 27, 2020HME News Staff
ACTON, Mass. - Insulet Corp. reported revenue of $738.2 million for 2019, a 31% increase compared to 2018. The company reported full-year revenue of $673.5 million for the Omnipod, broken down by U.S. revenue of $420.2 million and international revenue of $253.1 million, a 30% and 47% increase, respectively.Insulet reported revenue of $209.4 million for the fourth quarter of 2019, a 27% increase compared to the same period in 2018. Operating income was $18.2 million."2019 was a remarkable year for...
Insulet reports positive net income for first time
February 26, 2019HME News Staff
ACTON, Mass. - Insulet Corp. has reported net income of $9.9 million for the fourth quarter of 2018 compared to a net loss of $6.9 million for the same period in 2017.The company reported net income of $3.3 million for all of 2018 vs. a net loss of $26.8 million for 2017.It's the first time in Insulet's history that the company has achieved full-year positive operating income and net income.“Insulet had a remarkable 2018, achieving our third consecutive year of over 20% revenue growth, significantly...
Insulet reduces net loss
August 3, 2018HME News Staff
BILLERICA, Mass. - Insulet Corp., maker of the Omnipod Insulin Management System, reported revenues of $124.3 million for the second quarter, a 13% increase compared to the same period last year. It reported revenues of $78.1 million for the Omnipod in the U.S., a 19% increase. Insulet reported a net loss of $1.7 million for the second quarter compared to a net loss of $7.8 million for the same period last year. Among the company's highlights in the second quarter: It assumed direct European operations...